Skip to main content

Molecular Cytopathology Workshop

Tracking # 20-924332

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

Cytology specimens undergo different preparation techniques from histologic tissue and therefore have unique limitations and applicability. Further, the limited volume nature of cytological specimens require judicious triaging and prioritization of specific molecular tests, based on the tumor type. As such, it is critical for practicing cytopathologists to understand the strengths and limitations of the various testing platforms for our unique specimen types. This course will provide essential skills for trainees and practicing pathologists to gain confidence in various aspects of molecular cytopathology. Through improved training in molecular pathology, cytopathologists can adequately triage specimens to expedite clinically actionable testing and be able to implement changes in their own practice to better utilize cytology specimens for molecular testing. The course provides organ-specific detailed molecular training, as well as general teaching on molecular assays and test selection. The course will empower cytopathologists to serve as experts in molecular cytopathology for both test selection and results interpretation. TARGET AUDIENCE This educational activity is designed for pathologists, fellows/residents, cytotechnologists, and other members of the cytopathology community. LEARNING OBJECTIVES Build confidence in molecular test ordering and interpretation Understand the cytology specimen types available for molecular testing Review common testing methodologies Understand organ-specific testing recommendations and limitations

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

13h General (Cytology)

Clinical Laboratory Supervisor

13h General (Cytology)

Clinical Laboratory Technician

13h General (Cytology)

Clinical Laboratory Technologist

13h General (Cytology)

Public Health Director

13h General (Cytology)

Public Health Supervisor

13h General (Cytology)

Public Health Technician

13h General (Cytology)

Public Health Technologist

13h General (Cytology)

Disclosure statements

Maria D. Lozano, MD, PhD, MIACSpeaker: Roche, Pfizer, Astra Zeneca

Sinchita Roy-Chowdhuri, MD, PhD None

Giancarlo Troncone, MDAdvisor: Ely Lilly, Bristol Myers Squibb, GlaxoSmithKline

Paul VanderLaan, MD, PhD Consultant: Gala Therapeutics, Intuitive Surgical, Galvanize Therapeutics

Michiya Nishino, MD, PhD None

Michael J. Thrall, MD None

Aatur D. Singhi, MD, PhD Honorarium: Foundation Medicine

Ester Rossi, MD None

Vicki Jo, MD None

Chris VandenBussche, MD, PhD NCI SBIR Grant to Insitution: Thrive Early Detection, Advisor Board Member: Roche, Speaker Honorarium: Northwell Health

Vivian Weiss, MD, PhD None